Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
NCT01395069
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
162
Enrollment
OTHER
Sponsor class
Conditions
Macular Edema
Interventions
DRUG:
Nepafenac 0.1%
DRUG:
Ketorolac 0.5%
OTHER:
Placebo (sterile saline drops)
Sponsor
Queen's University